Main description:

This text is a reliable, validated, anatomically defined, and image-based tool to determine residue location and severity when performing fiberoptic endoscopic evaluation of swallowing (FEES). Based upon research by Drs. Leder and Neubauer, an easily interpreted, readily learned, and hierarchically organized pharyngeal residue severity rating scale was developed for speech-language pathologists, otolaryngologists, and other health care professionals who perform and interpret FEES. The Yale Pharyngeal Residue Severity Rating Scale works equally well for any swallow of interest, whether it is the first, subsequent clearing, or last swallow. The endoscopist simply has to match their chosen swallow with its scale mate.
The Yale Pharyngeal Residue Severity Rating Scale can be used for both clinical advantages and research opportunities. Clinically, clinicians can now accurately classify vallecula and pyriform sinus residue severity as none, trace, mild, moderate, or severe for diagnostic purposes, determination of functional therapeutic change, and precise dissemination of shared information. Research uses include tracking outcomes for clinical trials, investigating various swallowing interventions, demonstrating efficacy of specific interventions to reduce pharyngeal residue, determining morbidity and mortality associated with pharyngeal residue in different patient populations, and improving the training and accuracy of FEES interpretation by students and clinicians. The Yale Pharyngeal Residue Severity Rating Scale is an important addition to the deglutologist's tool box.

Contents:

Uniquely designed for
oncologists and general practitioners, this book offers clinicians
comprehensive guidelines when dealing with women at high risk for breast
cancer. Written by experts in the field on the cutting edge of this research,
the following questions will be answered for the reader by the end of the book:
Who is at elevated risk for breast cancer, who should be genetically screened,
when and how often should we obtain imaging and what type of imaging is
adequate, what medications are available for prevention, when is surgical
intervention appropriate, and finally, what lifestyle changes should be
implemented to prevent this disease?

With one in eight
women likely to contract breast cancer in her lifetime, the significance of
identifying and managing the high-risk patient is evident. Breakthroughs in the
identification of genes associated with breast carcinoma, particularly BRCA1
and 2, as well as other risk factors, influence not only how patients are
screened, but also how they are treated. Breast Cancer Prevention provides a
guided approach to prevention of breast cancer in women at elevated risk for
this malignancy.